Trial · NCT05057572
Registered outcomes29
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 29
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Complicated ascites (any of refractory ascites, SBP, AKI-HRS) | 1 year | |
| Secondary | Ascites resolution in both groups | 3 Months | Ascites well controlled with appropriate medical treatment, i.e, the minimum diuretic dose necessary to control weight gain and ascites formation that did not lead to diuretic-induced complications, such as renal impairment, hyponatremia, hypokalemia or hyperkalemia, or HE |
| Secondary | Ascites resolution in both groups | 6 Months | Ascites well controlled with appropriate medical treatment, i.e, the minimum diuretic dose necessary to control weight gain and ascites formation that did not lead to diuretic-induced complications, such as renal impairment, hyponatremia, hypokalemia or hyperkalemia, or HE |
| Secondary | Ascites resolution in both groups | 1 year | Ascites well controlled with appropriate medical treatment, i.e, the minimum diuretic dose necessary to control weight gain and ascites formation that did not lead to diuretic-induced complications, such as renal impairment, hyponatremia, hypokalemia or hyperkalemia, or HE |
| Secondary | Need and frequency of Large Volume Paracentesis | 1 year | |
| Secondary | Incidence of PICD in 1 year | 1 year | |
| Secondary | Mortality | 1 year | |
| Secondary | Change in grade of varices in both groups | 1 year | Change is defined as from garde I to garde II/ grade III |
| Secondary | Reduction in HVPG in both groups | 1 year | |
| Secondary | Change in MELD score in both groups | 3 months | Minimum MELD=6 Maximum MELD=40 |
| Secondary | Change in MELD score in both groups | 6 months | Minimum MELD=6 Maximum MELD=40 |
| Secondary | Change in MELD score in both groups | 1 year | Minimum MELD=6 Maximum MELD=40 |
| Secondary | Change in CTP score in both groups | 3 months | CTP Change is CTP- C to CTP- B \& CTP- B to CTP- A |
| Secondary | Change in CTP score in both groups | 6 months | CTP Change is CTP- C to CTP- B \& CTP- B to CTP- A |
| Secondary | Change in CTP score in both groups | 1 year | CTP Change is CTP- C to CTP- B \& CTP- B to CTP- A |
| Secondary | Incidence of HE in both groups | 6 months | |
| Secondary | Incidence of HE in both groups. | 1 year | |
| Secondary | Incidence of variceal bleed in both groups | 6 months | |
| Secondary | Incidence of variceal bleed in both groups | 1 year | |
| Secondary | Incidence of AKI in both groups | 6 months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05057572/registered